Pelvic lymph node metastases visualized on PSMA PET/CT prior to prostate cancer surgery independently predicts an increased risk for biochemical disease progression, a study found.
But difference in positive margin rates between usual planning and 3D virtual reality model planning groups not statistically significant
A novel scoring system could identify men at increased risk of death after prostatectomy who would benefit from adjuvant radiation therapy.
A recent study is the first to examine the association between pelvic inflammation and prostate cancer biology and outcomes.
Intraoperative pathologic assessment of tissue adjacent to the neurovascular bundles after removal of the prostate increases the likelihood of nerve-sparing surgery.
Although most men with low-risk prostate cancer are now managed initially with active surveillance, use of this approach remains suboptimal, according to investigators.
In patients with high-risk prostate cancer, negative PSMA PET/CT does not permit PLND avoidance, investigators cautioned.
Investigators compared the mental health status of men undergoing surgery, radiation therapy, and active surveillance for localized prostate cancer.
From March 23 to July 4, 2020, the number of men newly diagnosed with prostate cancer dropped 48.3% compared with the corresponding period in 2019, according to investigators.
Early salvage radiation therapy was defined as PSA levels of 0.2 to 0.5 ng/mL.
